Authors:
GHOUMARI AM
MOUAWAD R
ZERROUQI A
NIZARD C
PROVOST N
KHAYAT D
NAUS CCG
SOUBRANE C
Citation: Am. Ghoumari et al., ACTIONS OF HSVTK AND CONNEXIN43 GENE DELIVERY ON GAP JUNCTIONAL COMMUNICATION AND DRUG SENSITIZATION IN HEPATOCELLULAR-CARCINOMA, Gene therapy, 5(8), 1998, pp. 1114-1121
Authors:
GOEDHALS L
HERON JF
KLEISBAUER JP
PAGANI O
SESSA C
GIGER K
CAVALLI F
LUDWIG C
AAPRO M
BLEIBERG H
DEWASH G
DICATO M
TAGNON A
VANSTRAELEN D
VINDEVOGHEL A
ABRATT R
FALKSON G
BARLEY V
CARMICHAEL J
COLEMAN R
DAVIDSON N
GRIEVE R
HARPER P
ROBERTS J
RUSTIN G
NAMAN H
SCHNEIDER M
NOBLE A
NETTER P
CUPISSOL D
BALMES P
CALS L
KHAYAT D
CATIMEL G
DUTIN JP
BOUFETTE P
ADENIS L
MISSET J
COLLERY P
NOUVET G
CHAVAILLON JM
BLANCHON F
POIRIER R
ARNAUD A
LECAER H
CARLES P
MUIR J
BONNAUD F
MARQUESTE L
CLAVIER J
GUERIN J
TAYTARD A
KEIZER H
NORTIER J
SLEE P
WILS J
RODENBURG C
BURGHOUTS J
DEWIT R
GARCIAGIRON C
JIMENEZLACAVE A
CRUZHERNANDEZ J
MASSUTISUREDA B
HANS K
FUCHS R
KRIEGMAIR M
SCHULLER J
LAHOUSEN M
PANNUTI F
MONFARDINI S
NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
Authors:
ANTOINE EC
CHOLLET P
MONFARDINI S
SORIO R
AMBROSINI G
BENHAMMOUDA A
MAZEN MF
RAMAZEILLES C
AZLI N
KHAYAT D
Citation: Ec. Antoine et al., SEQUENTIAL ADMINISTRATION OF DOCETAXEL (D) (TAXOTERE(TM)) FOLLOWED BYAC IN FIRST LINE METASTATIC BREAST-CANCER (MBC) PATIENTS (PTS) - FINAL RESULTS, Annals of oncology, 9, 1998, pp. 91-91
Authors:
KRAKOWSKI I
MONIN S
DAHAN R
CHEVALIER H
KHAYAT D
SCHRAUB S
SERIN D
Citation: I. Krakowski et al., IMPACT OF REPEATED INVASIVE PROCEDURES IN ONCOLOGY - CONFRONTATION OFPHYSICIAN, NURSE AND PATIENT OPINIONS, Annals of oncology, 9, 1998, pp. 100-100
Authors:
ORCEL B
ANTOINE EC
BENHAMMOUDA A
VANNETZEL JM
LENSEIGNE S
SOUSSANLAZARD K
LEBRAS E
KHAYAT D
Citation: B. Orcel et al., INTERIM RESULT OF A SEQUENTIAL ADMINISTRATION OF DOCETAXEL FOLLOWED BY CISPLATIN-VINDESINE IN CHEMOTHERAPY NAIVE PATIENTS WITH INOPERABLE NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 458-458
Authors:
KEILHOLZ U
CONRADT C
LEGHA SS
KHAYAT D
SCHEIBENBOGEN C
THATCHER N
GOEY SH
GORE M
DORVAL T
HANCOCK B
PUNT CJA
DUMMER R
AVRIL MF
BROCKER EB
BENHAMMOUDA A
EGGERMONT AMM
PRITSCH M
Citation: U. Keilholz et al., RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 2921-2929
Authors:
MATHURIN P
RIXE O
CARBONELL N
BERNARD B
CLUZEL P
BELLIN MF
KHAYAT D
OPOLON P
POYNARD T
Citation: P. Mathurin et al., REVIEW ARTICLE - OVERVIEW OF MEDICAL TREATMENTS IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - AN IMPOSSIBLE METAANALYSIS, Alimentary pharmacology & therapeutics, 12(2), 1998, pp. 111-126
Authors:
GATZEMEIER U
MANEGOLD C
EBERHARD W
WILKE HJ
CHOMY F
CHOMY P
KHAYAT D
BLATTER J
SEEBER S
DRINGS P
Citation: U. Gatzemeier et al., IFOSFAMIDE AND GEMCITABINE - A PHASE-II TRIAL IN ADVANCED INOPERABLE NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(1), 1998, pp. 15-18
Authors:
BICHAT F
SOLISRECENDEZ G
POULLAIN MG
POUPON MF
KHAYAT D
BASTIAN G
Citation: F. Bichat et al., S9788 MODULATION OF P-GLYCOPROTEIN-RELATED AND MULTIDRUG-RELATED PROTEIN-MEDIATED MULTIDRUG-RESISTANCE BY SERVIER-9788 IN DOXORUBICIN-RESISTANT MCF7 CELLS, Biochemical pharmacology, 56(4), 1998, pp. 497-502
Authors:
ANTOINE EC
BENHAMMOUDA A
BERNARD A
YOUSSEF A
MORTIER N
GOZY M
NIZRI D
AUCLERC G
ROCHER MA
SOUBRANE CL
WEIL M
KHAYAT D
Citation: Ec. Antoine et al., SALPETRIERE HOSPITAL EXPERIENCE WITH BIOCHEMOTHERAPY IN METASTATIC MELANOMA, The cancer journal from Scientific American, 3, 1997, pp. 16-21
Authors:
BENGTSSON NO
FOCAN C
GUDGEON A
ILLIGER HJ
KHAYAT D
MURRAY R
NORTIER JWR
WAXMAN J
ZIELINSKI C
Citation: No. Bengtsson et al., A PHASE-III TRIAL COMPARING VOROZOLE (RIVIZOR(TM)) VERSUS AMINOGLUTETHIMIDE IN THE TREATMENT OF ADVANCED POSTMENOPAUSAL BREAST-CANCER, European journal of cancer, 33, 1997, pp. 656-656
Authors:
SPAETH D
BONNETERRE J
MARTY M
KHAYAT D
FACCHINI T
CONROY T
Citation: D. Spaeth et al., PHASE-II STUDIES OF 2 TRIAL REGIMENS OF TOPOTECAN AS 2ND-LINE SINGLE-AGENT THERAPY IN ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 704-704
Authors:
ANTOINE EC
ORCEL B
BENHAMMOUDA A
VANNETZEL JM
LENSEIGNE S
SOUSSANLAZARD K
LORET C
BERILLE J
DERENNE JP
KHAYAT D
Citation: Ec. Antoine et al., INTERIM RESULTS OF A SEQUENTIAL ADMINISTRATION OF DOCETAXEL (TAXOTERE(R)) FOLLOWED BY CISPLATIN-VINDESINE IN CHEMOTHERAPY NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 33, 1997, pp. 1085-1085
Authors:
CHEVALLIER B
CAPPELAERE P
SPLINTER T
FABBRO M
WENDLING JL
CALS L
CATIMEL G
GIOVANNINI M
KHAYAT D
BASTIT P
CLAVERIE N
Citation: B. Chevallier et al., A DOUBLE-BLIND, MULTICENTER COMPARISON OF INTRAVENOUS DOLASETRON MESILATE AND METOCLOPRAMIDE IN THE PREVENTION OF NAUSEA AND VOMITING IN CANCER-PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Supportive care in cancer, 5(1), 1997, pp. 22-30
Authors:
MOUAWAD R
MERLE S
ANTOINE EC
GOZY M
WEIL M
KHAYAT D
SOUBRANE C
Citation: R. Mouawad et al., STUDY OF INTRACELLULAR INTERLEUKIN-6 (IL-6) EXPRESSION IN METASTATIC MALIGNANT-MELANOMA (MMM) PATIENTS TREATED BY BIOCHEMOTHERAPY - CORRELATION WITH SERUM IL-6 LEVEL, The FASEB journal, 11(3), 1997, pp. 3152-3152
Authors:
ZERROUQI A
MOUAWAD R
GHOUMARI A
KHAYAT D
SOUBRANE C
Citation: A. Zerrouqi et al., ENHANCING OF TRANSGENE EXPRESSION IN VIRUS-FREE SYSTEM BY THE COTRANSFECTION WITH THE ADENOVIRUS VIRUS-ASSOCIATED-I AND VIRUS-ASSOCIATED-IIRNA GENES, The FASEB journal, 11(3), 1997, pp. 3198-3198
Authors:
ANTOINE EC
RIXE O
AUCLERC G
WEIL M
KHAYAT D
Citation: Ec. Antoine et al., DOCETAXEL - A REVIEW OF ITS ROLE IN BREAST-CANCER-TREATMENT, American journal of clinical oncology, 20(4), 1997, pp. 429-432
Authors:
RIXE O
COEFFIC D
ORCEL B
MAITRE B
BOREL C
BENHAMMOUDA A
PETIT T
KHAYAT D
DERENNE JP
Citation: O. Rixe et al., A PHASE-II STUDY OF CISPLATIN, 5-FLUOROURACIL, LEUCOVORIN, AND ETOPOSIDE IN ADVANCED NON-SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 20(2), 1997, pp. 128-131
Authors:
BICHAT F
MOUAWAD R
SOLISRECENDEZ G
KHAYAT D
BASTIAN G
Citation: F. Bichat et al., CYTOSKELETON ALTERATION IN MCF7R CELLS, A MULTIDRUG-RESISTANT HUMAN BREAST-CANCER CELL-LINE, Anticancer research, 17(5A), 1997, pp. 3393-3401
Authors:
GATZEMEIER U
MANEGOLD C
EBERHARD W
WILKE HJ
CHOMY F
CHOMY P
KHAYAT D
BLATTER J
SEEBER S
DRINGS P
Citation: U. Gatzemeier et al., A PHASE-II TRIAL OF GEMCITABINE AND IFOSFAMIDE IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 836-838
Authors:
COEFFIC D
BENHAMMOUDA A
ANTOINE EC
RIXE O
PARAISO D
AUCLERC G
RENODY N
MULARONI E
SOUBRANE C
WEIL M
MORTIER N
KHAYAT D
Citation: D. Coeffic et al., PRELIMINARY-RESULTS OF A PHASE I II STUDY OF PACLITAXEL, CISPLATIN, AND CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CARCINOMA/, Seminars in oncology, 24(1), 1997, pp. 38-40